Medicure Inc (MPH) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.144x

Based on the latest financial reports, Medicure Inc (MPH) has a cash flow conversion efficiency ratio of -0.144x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-1.82 Million ≈ $-1.32 Million USD) by net assets (CA$12.65 Million ≈ $9.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Medicure Inc to measure how much of total assets are equity-financed.

Medicure Inc - Cash Flow Conversion Efficiency Trend (2000–2025)

This chart illustrates how Medicure Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Medicure Inc (MPH) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Medicure Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medicure Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Akora Resources Ltd
AU:AKO
-0.058x
Hammer Metals Limited
F:6HM
-0.006x
Orgenesis Inc
NASDAQ:ORGS
0.193x
SKY E&M Co. Ltd
KQ:131100
0.027x
Edinburgh Worldwide Investment Trust plc
LSE:EWI
-0.013x
Cenntro Electric Group Ltd
NASDAQ:CENN
-0.019x
Aakash Exploration Services Limited
NSE:AAKASH
0.010x
Jupiter Fund Management Plc
LSE:JUP
0.024x

Annual Cash Flow Conversion Efficiency for Medicure Inc (2000–2025)

The table below shows the annual cash flow conversion efficiency of Medicure Inc from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see Medicure Inc stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CA$12.91 Million
≈ $9.34 Million
CA$-560.00K
≈ $-405.10K
-0.043x -165.46%
2024-12-31 CA$20.78 Million
≈ $15.03 Million
CA$1.38 Million
≈ $996.10K
0.066x -36.58%
2023-12-31 CA$19.90 Million
≈ $14.39 Million
CA$2.08 Million
≈ $1.50 Million
0.104x +20.07%
2022-12-31 CA$21.00 Million
≈ $15.19 Million
CA$1.83 Million
≈ $1.32 Million
0.087x -59.83%
2021-12-31 CA$18.41 Million
≈ $13.32 Million
CA$3.99 Million
≈ $2.89 Million
0.217x +285.19%
2020-12-31 CA$19.15 Million
≈ $13.85 Million
CA$-2.24 Million
≈ $-1.62 Million
-0.117x +78.47%
2019-12-31 CA$26.94 Million
≈ $19.49 Million
CA$-14.64 Million
≈ $-10.59 Million
-0.543x -6219.98%
2018-12-31 CA$83.59 Million
≈ $60.47 Million
CA$742.27K
≈ $536.95K
0.009x -96.73%
2017-12-31 CA$80.71 Million
≈ $58.38 Million
CA$21.92 Million
≈ $15.86 Million
0.272x +65.07%
2016-12-31 CA$38.96 Million
≈ $28.18 Million
CA$6.41 Million
≈ $4.64 Million
0.165x +414.14%
2015-12-31 CA$4.46 Million
≈ $3.23 Million
CA$142.79K
≈ $103.30K
0.032x +126.41%
2014-12-31 CA$-3.91 Million
≈ $-2.83 Million
CA$473.97K
≈ $342.86K
-0.121x -542.33%
2013-12-31 CA$-5.88 Million
≈ $-4.25 Million
CA$110.88K
≈ $80.21K
-0.019x -108.24%
2012-12-31 CA$-4.33 Million
≈ $-3.13 Million
CA$-990.48K
≈ $-716.50K
0.229x +199.88%
2011-12-31 CA$-1.82 Million
≈ $-1.32 Million
CA$417.29K
≈ $301.86K
-0.229x -1190.93%
2010-12-31 CA$-26.89 Million
≈ $-19.45 Million
CA$477.48K
≈ $345.40K
-0.018x -130.50%
2009-12-31 CA$-24.96 Million
≈ $-18.05 Million
CA$-1.45 Million
≈ $-1.05 Million
0.058x -89.08%
2008-12-31 CA$-19.55 Million
≈ $-14.14 Million
CA$-10.42 Million
≈ $-7.54 Million
0.533x -91.65%
2007-12-31 CA$-6.56 Million
≈ $-4.74 Million
CA$-41.86 Million
≈ $-30.28 Million
6.386x +967.70%
2006-12-31 CA$34.31 Million
≈ $24.82 Million
CA$-25.25 Million
≈ $-18.26 Million
-0.736x -115.75%
2005-12-31 CA$37.17 Million
≈ $26.89 Million
CA$-12.68 Million
≈ $-9.17 Million
-0.341x +79.25%
2004-12-31 CA$7.34 Million
≈ $5.31 Million
CA$-12.07 Million
≈ $-8.73 Million
-1.644x -476.36%
2003-12-31 CA$21.57 Million
≈ $15.60 Million
CA$-6.15 Million
≈ $-4.45 Million
-0.285x +64.61%
2002-12-31 CA$4.94 Million
≈ $3.58 Million
CA$-3.98 Million
≈ $-2.88 Million
-0.806x -73.80%
2001-12-31 CA$8.99 Million
≈ $6.50 Million
CA$-4.17 Million
≈ $-3.01 Million
-0.464x +34.57%
2000-12-31 CA$3.85 Million
≈ $2.79 Million
CA$-2.73 Million
≈ $-1.97 Million
-0.709x --

About Medicure Inc

V:MPH Canada Drug Manufacturers - Specialty & Generic
Market Cap
$9.81 Million
CA$13.57 Million CAD
Market Cap Rank
#27065 Global
#1121 in Canada
Share Price
CA$1.30
Change (1 day)
+10.17%
52-Week Range
CA$0.90 - CA$1.43
All Time High
CA$10.58
About

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary … Read more